Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Se-Woong Oh"'
Autor:
Byoung Chul Cho, Hye Ryun Kim, Soongyu Choi, Se-Woong Oh, Young-Sung Lee, Dong Kyun Kim, Ho-Juhn Song, Jong Sung Koh, Sung Sook Lee, Kyoung-Ho Pyo, Han Na Kang, Mi Ran Yun, Soyoung Kim, Chae-Won Park, Seok-Young Kim, Min Hee Hong, Jiyeon Yun
Supplementary Figure legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d8bf2bc5e32c18679e306b597c4beaa
https://doi.org/10.1158/1078-0432.22471416.v1
https://doi.org/10.1158/1078-0432.22471416.v1
Autor:
Byoung Chul Cho, Hye Ryun Kim, Soongyu Choi, Se-Woong Oh, Young-Sung Lee, Dong Kyun Kim, Ho-Juhn Song, Jong Sung Koh, Sung Sook Lee, Kyoung-Ho Pyo, Han Na Kang, Mi Ran Yun, Soyoung Kim, Chae-Won Park, Seok-Young Kim, Min Hee Hong, Jiyeon Yun
Supplementary Figure S1,S2,and S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62bdd0f85566ae2d42fdb19cca7f65cd
https://doi.org/10.1158/1078-0432.22471419
https://doi.org/10.1158/1078-0432.22471419
Autor:
Kyoung-Ho Pyo, Dong Kwon Kim, Se-Woong Oh, Gyu-Jin Lee, Ho-Woong Kang, Jae Hwan Kim, Youngseon Byeon, Young Seob Kim, Chun-Bong Synn, Wongeun Lee, Su Hwan Lee, Seul Lee, Seung Min Yang, Soyeon Lee, Yunjoo Joo, Eun Ji Lee, Sun Min Lim, Byoung Chul Cho
Publikováno v:
Cancer Research. 82:5481-5481
Background: The IDO is an enzyme responsible for catabolizing tryptophan (Trp) to kynurenine (Kyn). The kynurenine exert important immunosuppressive functions by activating Treg cells and myeloid-derived suppressor cells. YH29407 is a novel IDO1 inhi
Autor:
Eunjung Lee, Hyejin Chung, Yangsoon Lee, Eun-jung Lee, Young Bong Park, Ju Young Park, Sujin Ahn, Junhwan Kim, Kyoung Kyu Ahn, Kyeongsu Park, Wonjun Son, Donghoon Yeom, Jaeho Jung, Jonghwa Won, Se-Woong Oh
Publikováno v:
Cancer Research. 82:1139-1139
Although HER2-targeted therapies such as Herceptin® (trastuzumab) have dramatically improved outcomes for solid cancer patients with HER2 overexpression, it remains a challenge to cure the HER2 positive cancer patients with resistance to current HER
Autor:
Sung Sook Lee, Young Sung Lee, Min Hee Hong, Mi Ran Yun, Kyoung Ho Pyo, Byoung Chul Cho, Koh Jong Sung, Hye Ryun Kim, Han Na Kang, So-Young Kim, Ho Juhn Song, Dong-Kyun Kim, Se Woong Oh, Soongyu Choi, Chae Won Park, Jiyeon Yun, Seok Young Kim
Publikováno v:
Clinical Cancer Research. 25:2575-2587
Purpose: Given that osimertinib is the only approved third-generation EGFR-TKI against EGFR activating and resistant T790M mutated non–small cell lung cancer (NSCLC), additional mutant-selective inhibitors with a higher efficacy, especially for bra
Autor:
Jong-Suk Park, Se-Woong Oh, Kyoung Ho Pyo, Byoung Chul Cho, Dong Kwon Kim, Ho-Woong Kang, Gyu-Jin Lee, Sun Min Lim, Do Hee Kim
Publikováno v:
Cancer Research. 81:1787-1787
Background: The indoleamine 2,3-dioxygenase (IDO), is an enzyme responsible for catabolizing tryptophan (Trp) to kynurenine (Kyn). The depletion of tryptophan and the increase in kynurenine exert important immunosuppressive functions by activating T
Autor:
Dae Won Kim, Sung Byungje, Yangsoon Lee, KyeongBae Kim, Su Jin Ahn, Wonjun Son, Yeom Donghoon, J.K. Lee, Chung Hyejin, Weon-Kyoo You, Ju Young Park, Eun Jung Kim, Young Bong Park, Song Daehae, Mikyeong Ju, Eom Jaehyun, Ahn Jinhyung, Jaeho Jung, Moo Young Song, Jung Uijung, Jong Gyun Kim, Jun Hwan Kim, Eunjung Lee, Park Kyeongsu, Se-Woong Oh, Min Hyeok Jee, Kyoung Kyu Ahn, Byung Hyun Choi
Publikováno v:
Cancer Research. 80:6524-6524
4-1BB (TNFSF9, CD137) is a member of the tumor necrosis factor receptor superfamily that functions as a potent costimulator to immune cells, especially T-cell. Although current 4-1BB-targeted strong agonistic antibody exhibit a considerable anti-tumo
Autor:
Hyun-Mo Koo, Soongyu Choi, Tae-Wang Kim, Se-Woong Oh, Ho-Woong Kang, Jong-Suk Park, Jin-Hwi Park
Publikováno v:
Cancer Research. 79:3915-3915
Phosphatidylinositol 3-kinase (PI3K) plays critical roles in numerous intracellular processes. Of the four known subtypes, PI3Kδ subtype is primarily expressed in immune cells and has been reported to promote B cell differentiation and regulatory T
Autor:
Jong Sung Koh, So-Young Kim, Young Sung Lee, Seok-Young Kim, Jiyeon Yun, Kyoung Ho Pyo, Byoung Chul Cho, Han Na Kang, Min Hee Hong, Mi Ran Yun, Soongyu Choi, Chae Won Park, Ho-Juhn Song, Se-Woong Oh
Publikováno v:
Cancer Research. 78:4790-4790
EGFR mutated lung cancer shows approximately 10-15% of non-small cell lung cancer (NSCLC). Although the best therapeutic EGFR tyrosine kinase inhibitors (TKIs) targeting mutant EGFR, such as gefitinib and erlotinib, are used in the first line treatme
Autor:
Je-Hwan Lee, Sung-Doo Kim, Jong Heun Lee, Jung-Hee Lee, Yunsuk Choi, Se-Woong Oh, Young-Hee Byun, Dae-Young Kim, Eun-Hye Hur, Sungsook Lee, Bon-Kwan Goo, Kyoo-Hyung Lee, Kyung-Yun Jung
Publikováno v:
Cancer Research. 71:4518-4518
Background: Aberrant activation of Wnt signaling has been implicated in the pathogenesis of hematologic malignancies. CWP232291 is a novel small molecule that inhibits Wnt signaling through promotion of beta-catenin degradation. In vitro and in vivo